New heart valve implant tested for patients too risky for open surgery
Disease control
Ongoing
This study is testing the ACURATE Neo2, a new type of artificial heart valve, in patients from the Middle East who have severe, symptomatic aortic stenosis. It involves 51 patients who are at intermediate or high risk for open-heart surgery and are getting the valve implanted via…
Sponsor: Ceric Sàrl • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC